📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel immune GTPases regulating lymphocyte apoptosis/survival

Lead Research Organisation: Babraham Institute
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

Mature T and B lymphocytes are the essential mediators of specific immunity and immunological memory in vertebrates. Characteristic features of these cells are their long life (months to years) and their relative quiescence, which is maintained unless and until they encounter a ‘cognate’ substance (an antigen) that can activate them to respond and to initiate a protective immune response. The maintenance of the long lifespan and quiescence of lymphocytes is now recognised to require the active engagement of several signalling pathways. It is also appreciated that a healthy and diverse lymphocyte repertoire can contribute significantly to healthy ageing. Our work is focussed on one family of proteins, the GIMAP GTPases, some of which are required for lymphocyte survival. By using unbiased approaches to identifying proteins which interact with members of the GIMAP family we aim to understand more about the mechanisms underlying lymphocyte survival in general and to uncover new ways whereby lymphocytes may be manipulated to enhance or to suppress immune responsiveness, where desirable.

Planned Impact

unavailable

Publications

10 25 50
 
Description Through this research we developed new knowledge about the possible mechanism(s) of action of one of a family of GTPase enzymes known to be involved in the normal survival of lymphocytes. This enzyme is called GIMAP6 and we confirmed earlier work in our laboratory showing that GIMAP6 interacts with a protein (named GABARAPL2) involved in cellular autophagy (an intracellular 'cleansing' and recycling process). We showed further which parts of the two proteins are required for the interaction to take place. We also found that GIMAP6 interacts with its sibling protein GIMAP7. This is an interesting result because GIMAP GTPases are known to be related to other GTPases called septins which function by forming polymers made up of different members of the septin family.
Exploitation Route This work helped confirm our interest in GIMAP6 and has encouraged ourselves and others to look further into role that this protein plays, including in human cells.
Sectors Healthcare

Pharmaceuticals and Medical Biotechnology

 
Description The knowledge we have developed on the Gimap proteins is just beginning to inform interest in these proteins in clinical settings and this aspect is likely to develop in the coming years.
First Year Of Impact 2012
Sector Healthcare
Impact Types Societal